Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

The Hospira Symbiq Infusion System is intended for the delivery of fluids Recalled by Hospira Inc. Due to The devices secondary audio signal fails to activate.

Date: February 4, 2013
Company: Hospira Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Hospira Inc. directly.

Affected Products

The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.

Quantity: 2,791 units

Why Was This Recalled?

The devices secondary audio signal fails to activate.

Where Was This Sold?

This product was distributed to 22 states: AL, CA, CT, DE, FL, HI, IL, IN, IA, LA, ME, MD, MA, MI, MN, NJ, NY, NC, PA, SD, TX, WA

Affected (22 states)Not affected

About Hospira Inc.

Hospira Inc. has 245 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report